These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 6429563)
1. Discrimination of the amphetamine cue. Effects of A, B and mixed type inhibitors of monoamine oxidase. Porsolt RD; Pawelec C; Roux S; Jalfre M Neuropharmacology; 1984 May; 23(5):569-73. PubMed ID: 6429563 [TBL] [Abstract][Full Text] [Related]
2. Evidence that a preferred substrate for type B monoamine oxidase mediates stimulus properties of MAO inhibitors: a possible role for beta-phenylethylamine in the cocaine cue. Colpaert FC; Niemegeers CJ; Janssen PA Pharmacol Biochem Behav; 1980 Oct; 13(4):513-7. PubMed ID: 6107935 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of the stereoisomers of deprenyl for amphetamine-like discriminative stimulus effects in rats. Yasar S; Schindler CW; Thorndike EB; Szelenyi I; Goldberg SR J Pharmacol Exp Ther; 1993 Apr; 265(1):1-6. PubMed ID: 8473997 [TBL] [Abstract][Full Text] [Related]
4. Drug discrimination analysis of pseudoephedrine in rats. Tongjaroenbuangam W; Meksuriyen D; Govitrapong P; Kotchabhakdi N; Baldwin BA Pharmacol Biochem Behav; 1998 Feb; 59(2):505-10. PubMed ID: 9477001 [TBL] [Abstract][Full Text] [Related]
5. A comparison of drug-seeking behavior maintained by D-amphetamine, L-deprenyl (selegiline), and D-deprenyl under a second-order schedule in squirrel monkeys. Yasar S; Gaál J; Panlilio LV; Justinova Z; Molnár SV; Redhi GH; Schindler CW Psychopharmacology (Berl); 2006 Jan; 183(4):413-21. PubMed ID: 16292593 [TBL] [Abstract][Full Text] [Related]
6. The monoamine oxidase inhibitor phenelzine enhances the discriminative stimulus effect of nicotine in rats. Wooters TE; Bardo MT Behav Pharmacol; 2007 Nov; 18(7):601-8. PubMed ID: 17912044 [TBL] [Abstract][Full Text] [Related]
7. Metabolic transformation plays a primary role in the psychostimulant-like discriminative-stimulus effects of selegiline [(R)-(-)-deprenyl]. Yasar S; Justinova Z; Lee SH; Stefanski R; Goldberg SR; Tanda G J Pharmacol Exp Ther; 2006 Apr; 317(1):387-94. PubMed ID: 16352699 [TBL] [Abstract][Full Text] [Related]
8. Characterizing withdrawal in rats following repeated drug administration using an amphetamine-vehicle-haloperidol drug discrimination. Stadler JR; Caul WF; Barrett RJ Psychopharmacology (Berl); 1999 Apr; 143(3):219-26. PubMed ID: 10353423 [TBL] [Abstract][Full Text] [Related]
9. d-amphetamine "cue" generalizes to social defeat stress: behavioral sensitization and attenuated accumbens dopamine. Miczek KA; Mutschler NH; van Erp AM; Blank AD; McInerney SC Psychopharmacology (Berl); 1999 Nov; 147(2):190-9. PubMed ID: 10591887 [TBL] [Abstract][Full Text] [Related]
10. Effects of monoamine oxidase inhibitors on cocaine discrimination in rats. Gatch MB; Taylor CM; Flores E; Selvig M; Forster MJ Behav Pharmacol; 2006 Mar; 17(2):151-9. PubMed ID: 16495723 [TBL] [Abstract][Full Text] [Related]
11. Discriminative properties of the psychostimulant dl-cathinone in a two lever operant task. Lack of evidence for dopaminergic mediation. Goudie AJ; Atkinson J; West CR Neuropharmacology; 1986 Jan; 25(1):85-94. PubMed ID: 2869439 [TBL] [Abstract][Full Text] [Related]
12. Attenuation of the amphetamine discriminative cue in rats with the atypical antipsychotic olanzapine. Mechanic JA; Wasielewski JA; Carl KL; Holloway FA Pharmacol Biochem Behav; 2002 Jul; 72(4):767-77. PubMed ID: 12062565 [TBL] [Abstract][Full Text] [Related]
14. Drug discrimination in rats: evidence for amphetamine-like cue state following chronic haloperidol. Barrett RJ; Steranka LR Pharmacol Biochem Behav; 1983 Apr; 18(4):611-7. PubMed ID: 6867066 [TBL] [Abstract][Full Text] [Related]
15. Paroxetine, a selective 5-hydroxytryptamine uptake inhibitor with antidepressant properties, lacks amphetamine-like stimulus properties in an operant drug discrimination bioassay in rodents. Goudie AJ; Dubicki W; Leathley M J Pharm Pharmacol; 1988 Mar; 40(3):192-6. PubMed ID: 2899149 [TBL] [Abstract][Full Text] [Related]
16. Long-lasting rebound cue effects following single doses of nicotine and amphetamine: implications for understanding tolerance. Barrett RJ; Caul WF; Stadler JR; Smith RL Psychopharmacology (Berl); 2001 Oct; 157(4):349-57. PubMed ID: 11605093 [TBL] [Abstract][Full Text] [Related]
17. Drug discrimination is a continuous rather than a quantal process following training on a VI-TO schedule of reinforcement. Barrett RJ; Caul WF; Huffman EM; Smith RL Psychopharmacology (Berl); 1994 Jan; 113(3-4):289-96; discussion 297-303. PubMed ID: 7862836 [TBL] [Abstract][Full Text] [Related]
18. The 5-HT3 receptor partial agonist MD-354 (meta-chlorophenylguanidine) enhances the discriminative stimulus actions of (+)amphetamine in rats. Dukat M; Wesolowska A; Young R; Glennon RA Pharmacol Biochem Behav; 2007; 87(2):203-7. PubMed ID: 17540440 [TBL] [Abstract][Full Text] [Related]
19. Role of dopamine in d-amphetamine-induced discriminative responding. Ho BT; Huang JT Pharmacol Biochem Behav; 1975; 3(6):1085-92. PubMed ID: 1223898 [TBL] [Abstract][Full Text] [Related]
20. Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo. Lamensdorf I; Youdim MB; Finberg JP J Neurochem; 1996 Oct; 67(4):1532-9. PubMed ID: 8858937 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]